FOR IMMEDIATE RELEASE March 8, 2023 The bipartisan, bicameral legislation would expand access to methadone for the treatment of opioid use disorder Rockville, MD – The American Society of Addiction Medicine (ASAM) and the National Alliance for Medication Assisted Recovery (NAMA Recovery) today applauded Senators Edward Markey (MA) and Rand Paul (KY) and Representatives Donald Norcross…
Read more
The federal regulations in 42 CFR Part 8 (that oversee the use of buprenorphine and methadone in opioid treatment programs/”methadone clinics”) are being revised! There is a Notice of Proposed Rulemaking (NPRM) currently open in the federal register where organizations and individuals may leave public comments on the proposed new rules. Overall, the proposed revisions…
Read more
HIPAA is not good enough for criminalized and stigmatized health information, such as records related to substance use disorder (SUD) care! Aligning 42 CFR Part 2 (the federal regulations governing SUD treatment records) with HIPAA will not only discourage people from entering life-saving addiction treatment, but it will also put patients at risk of arrest, prosecution, incarceration, and discrimination based on their past substance use.
The 2022 Richard Lane/Robert Holden Patient Advocacy Award was presented at an Awards Reception held in conjunction with the 2022 Conference of the American Association for the Treatment of Opioid Dependence (AATOD) in Baltimore, Maryland on November 2, 2022. Richard Lane/Robert Holden Patient Advocacy Award Richard Lane was a long-term heroin user who, upon release…
Read more
The 2022 Certified MAT Advocacy (CMA) training course will be held on October 20, 2022, in Baltimore!
Richard Lane was a long-term heroin user who, upon release from prison in 1967, was instrumental in establishing one of the Nation’s first opioid treatment programs. In 1974, he became the Executive Director of Man Alive and later served as Vice President of the American Methadone Treatment Association (now AATOD) and as Vice Chairman of…
Read more
“The opioid crisis poses an extraordinary challenge to communities throughout our country. The Department of Justice (the Department) has responded with a comprehensive approach prioritizing prevention, enforcement, and treatment. This includes enforcing the Americans with Disabilities Act (ADA), which prohibits discrimination against people in recovery from opioid use disorder (OUD) who are not engaging in…
Read more
FOR IMMEDIATE RELEASE Friday, March 25, 2022 INDIANAPOLIS – Today, the Justice Department found that the Indiana State Board of Nursing (Nursing Board) violated the Americans with Disabilities Act (ADA) by prohibiting nurses who take medication to treat Opioid Use Disorder (OUD) from participating in the Indiana State Nursing Assistance Program. The program assists in…
Read more
NAMA Recovery is saddened to report the passing of a long-standing member of our Board of Directors. Paul Edward Bowman, Jr, 58, passed away on November 22, 2021. Paul was born in Boston, MA and lived most of his life in Quincy, MA. Paul served Massachusetts residents for over 25 years working for the Massachusetts…
Read more
May 6, 2019 Dr. Joseph was one of the important influences on addiction and criminal justice during the latter 20th and early 21st century. For more than 50 years he has worked as a social research scientist in the interrelated fields of addiction, treatment, criminal justice, street studies, homelessness, basic research and program development at…
Read more
Recent Comments